Life Sciences

Monitor PE activity in life sciences including pharmaceuticals, biotech, medical devices, and contract research organizations. Follow healthcare innovation and commercialization strategies.

Ampersand Exits TJO@Pack to Alcami in Strategic CDMO Consolidation

Ampersand Exits TJO@Pack to Alcami in Strategic CDMO Consolidation

May 5, 2026

Healthcare

+5

Windward Bio Raises $165M to Challenge Immunology Giants

Windward Bio Raises $165M to Challenge Immunology Giants

May 4, 2026

Healthcare

+5

PinnaqL Acquires Pharma Resource Group in Scientific Advisory Push

PinnaqL Acquires Pharma Resource Group in Scientific Advisory Push

May 1, 2026

Buy-and-build

+5

Establishment Labs Locks In $150M Refinancing Before Rate Cuts

Establishment Labs Locks In $150M Refinancing Before Rate Cuts

May 1, 2026

Healthcare

+5

MUSC Partners with Revival Healthcare Capital in $100M+ Deal

MUSC Partners with Revival Healthcare Capital in $100M+ Deal

Apr 29, 2026

Healthcare

+5

HealthCare Royalty Buys Into $500M Modeyso Revenue Stream

HealthCare Royalty Buys Into $500M Modeyso Revenue Stream

Apr 22, 2026

Healthcare

+5

THL Partners Bets Big on Clinical Trials as Celerion Changes Hands

THL Partners Bets Big on Clinical Trials as Celerion Changes Hands

Apr 22, 2026

Healthcare

+5

H.I.G. Capital Exits Celerion in Strategic Sale to Caidya

H.I.G. Capital Exits Celerion in Strategic Sale to Caidya

Apr 22, 2026

Healthcare

+5

OrbiMed Backs Nucleus RadioPharma with $50M to Scale Radioligand Therapy Production

OrbiMed Backs Nucleus RadioPharma with $50M to Scale Radioligand Therapy Production

Apr 22, 2026

Healthcare

+5

Oncology Ventures Closes $62M Fund II on Healthcare Bet

Oncology Ventures Closes $62M Fund II on Healthcare Bet

Apr 22, 2026

Healthcare

+6

5th Century Partners Elevates Will Smith to Partner

5th Century Partners Elevates Will Smith to Partner

Apr 14, 2026

Healthcare

+5

Adcendo Raises $75M to Challenge ADC Giants with Novel Linker Tech

Adcendo Raises $75M to Challenge ADC Giants with Novel Linker Tech

Apr 14, 2026

Healthcare

+5

Premier Biotech Expands Reach with GH Solutions Acquisition

Premier Biotech Expands Reach with GH Solutions Acquisition

Apr 9, 2026

Healthcare

+5

Jeito Capital Closes €1B Fund II at Record Scale

Jeito Capital Closes €1B Fund II at Record Scale

Apr 8, 2026

Healthcare

+5

Frazier Healthcare Elevates Two to GP as PE Firms Chase Talent

Frazier Healthcare Elevates Two to GP as PE Firms Chase Talent

Mar 31, 2026

Healthcare

+5

Prescient Acquires Dolon to Expand Drug Pricing Capabilities

Prescient Acquires Dolon to Expand Drug Pricing Capabilities

Mar 30, 2026

Healthcare

+5

PharmaTech Bets $50M on U.S. Drug Supply as China Tariffs Bite

PharmaTech Bets $50M on U.S. Drug Supply as China Tariffs Bite

Mar 23, 2026

Healthcare

+4

QHP Converts $1.1B Azurity Hold Into Continuation Vehicle

QHP Converts $1.1B Azurity Hold Into Continuation Vehicle

Mar 18, 2026

Secondaries

+6

Prendio and BioProcure Tap Industry Veteran Larry Birch as CEO

Prendio and BioProcure Tap Industry Veteran Larry Birch as CEO

Mar 17, 2026

Software/SaaS

+3

NanoImaging Services Taps Fraser McLeod as CEO for Growth Push

NanoImaging Services Taps Fraser McLeod as CEO for Growth Push

Mar 10, 2026

Healthcare

+5

Agilent Acquires Biocare Medical for $925M in Pathology Push

Agilent Acquires Biocare Medical for $925M in Pathology Push

Mar 9, 2026

Healthcare

+5

Lone Star Takes $4.7B Bite Out of Lonza's Capsules Empire

Lone Star Takes $4.7B Bite Out of Lonza's Capsules Empire

Mar 6, 2026

Healthcare

+5

H.I.G. Realty Partners with NHS Trust on London Life Sciences Hub

H.I.G. Realty Partners with NHS Trust on London Life Sciences Hub

Jan 20, 2026

Healthcare

+6

Turn/River Bets $200M on Lab Software Leader StarLIMS

Turn/River Bets $200M on Lab Software Leader StarLIMS

Jan 15, 2026

Technology

+8